|1.||Kim, Seung U: 17 articles (01/2014 - 01/2009)|
|2.||Kasahara, Noriyuki: 9 articles (02/2015 - 01/2003)|
|3.||Yi, Bo-Rim: 9 articles (01/2014 - 09/2011)|
|4.||Choi, Kyung-Chul: 9 articles (01/2014 - 09/2011)|
|5.||Hamada, H: 9 articles (08/2012 - 01/2000)|
|6.||Harris, Reuben S: 6 articles (11/2015 - 12/2013)|
|7.||Pierrefite-Carle, V: 6 articles (01/2009 - 03/2000)|
|8.||Jolly, Douglas J: 5 articles (02/2015 - 02/2012)|
|9.||Altaner, Cestmir: 5 articles (09/2014 - 10/2008)|
|10.||Hwang, Kyung-A: 5 articles (01/2014 - 09/2011)|
07/01/2009 - "In a gene-directed prodrug activation system using cytosine deaminase, these adenoviruses proved to be effective in eradicating primary pancreatic tumor cells. "
01/01/2013 - "This study was conducted to investigate enhancement of anti-tumor effects of the lentogenic Newcastle disease virus Clone30 strain (NDV rClone30) expressing cytosine deaminase (CD) gene against tumor cells and in murine groin tumor-bearing models. "
02/01/2008 - "In this study, we assessed the ability of a highly tumor-selective oncolytic vaccinia virus armed with a yeast cytosine deaminase gene to infect and lyse human and murine ovarian tumors both in vitro and in vivo. "
08/01/2004 - "In this study, we compared oral and intraperitoneal 5-FC administration in rats bearing a wild-type and a cytosine deaminase-expressing liver tumors. "
06/01/2004 - "The object of this study was to generate a recombinant adenoviral vector system which would generate tumor cell specific expression of cytosine deaminase (CD) gene. "
04/01/2000 - "[Experimental study on human pancreatic carcinoma treated by cytosine deaminase gene therapy]."
10/01/2010 - "We used transfected SW480 human colon carcinoma cells (SW480/CMVCD), expressing CMV-IE promoter-driven bacterial cytosine deaminase (CD) gene. "
05/15/2006 - "The treatment potential of cytosine deaminase (CD) gene therapy combined with radiation treatment was evaluated in vitro and in vivo using a 4T1 murine breast carcinoma model. "
01/01/2006 - "Effective antitumoral immune responses are not induced by cytosine deaminase suicide gene transfer in a syngeneic rat pancreatic carcinoma model."
04/01/2003 - "To evaluate the killing effects of the cytosine deaminase (CD) gene mediated by an adenovirus vector on human pancreatic carcinoma in vitro and in vivo. "
|3.||Glioblastoma (Glioblastoma Multiforme)
01/01/2012 - "Results obtained in a preclinical study using mesenchymal stem cells engineered to express cytosine deaminase provided evidence that stem cell based gene therapy might also attack glioblastoma stem cells and therefore be curative. "
04/01/2007 - "Cytosine deaminase/5-fluorocytosine exposure induces bystander and radiosensitization effects in hypoxic glioblastoma cells in vitro."
03/01/2011 - "In this study, we have thus critically evaluated a panel of human and rodent glioma/glioblastoma cell lines (U-87MG, U-118MG, LN-18, LN-229, 8-MG-BA, 42-MG-BA, A-172, T-98G, UVW, C6, 9L, G-26, GL-261, Tu-2449, Tu-9648) with respect to RCR virus vector spread, sensitivity towards the cytosine deaminase (CD)/5-flurocytosine (5-FC)/5-flurouracil (5-FU) suicide system, and orthotopic growth characteristics in mice to identify suitable preclinical animal models for the development of a glioblastoma gene therapy. "
03/15/2014 - "In this study, we evaluated the therapeutic efficacy of human mesenchymal stem cells derived from bone marrow and from adipose tissue, engineered to express the suicide gene cytosine deaminase::uracil phosphoribosyltransferase to treat intracerebral rat C6 glioblastoma in a simulated clinical therapeutic scenario. "
02/01/2002 - "Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas."
|4.||Brain Neoplasms (Brain Tumor)
09/01/2013 - "Previously, we developed a therapeutic strategy against metastatic brain tumors using a human NSC line (F3) expressing cytosine deaminase (F3.CD). "
01/01/2013 - "Previously, we showed that MSCs could be utilized to deliver a bacterial cytosine deaminase (CD) suicide gene to brain tumors. "
10/15/2010 - "Here, we showed a potential ex vivo therapy that used mesenchymal stem cells (MSCs) as cellular vehicles to deliver a bacterial suicide gene, cytosine deaminase (CD) to brain tumors. "
01/01/2007 - "Towards this end, we have assessed a conditionally replication-competent, gamma(1)34.5-deleted herpes simplex virus type 1 (HSV-1) expressing cytosine deaminase (CD) for treatment of malignant brain tumors. "
05/16/1997 - "coli cytosine deaminase (CD) gene instead of the commonly used HSV-TK gene in the gene therapy of brain tumors, we constructed a retrovirus vector carrying the CD gene. "
02/01/2012 - "The purpose of this study was to evaluate the antitumor effect of cytosine deaminase (CD)-expressing MSCs in a rat C6 glioma model. "
01/01/2009 - "Antitumor efficiency of the cytosine deaminase/5-fluorocytosine suicide gene therapy system on malignant gliomas: an in vivo study."
01/01/2015 - "Three-dimensional assessment of bystander effects of mesenchymal stem cells carrying a cytosine deaminase gene on glioma cells."
08/01/2014 - "We are developing a retroviral replicating vector (RRV) encoding cytosine deaminase as an anticancer agent for gliomas. "
05/01/2014 - "We have examined photochemical internalization (PCI) as a method for the non-viral transfection of the cytosine deaminase (CD) suicide gene into glioma cells. "
|9.||Caspase 3 (Caspase-3)
|10.||TNF-Related Apoptosis-Inducing Ligand
|1.||Heterologous Transplantation (Xenotransplantation)
|3.||Drug Therapy (Chemotherapy)